ANGO

SEC source: 0001140361-17-030639 · doc1.xml · nonDerivative · entry 1

Meteny Dennis S · CIK 0001289336 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,127

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-17-030643 · doc1.xml · derivative · entry 3

JOHNSON WESLEY · CIK 0001258791 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,000 shares

Expires 2017-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Options for one-third of the shares each became exercisable on 08/03/2011, 08/03/2012 and 08/03/2013, respectively.

SEC source: 0001140361-17-030643 · doc1.xml · nonDerivative · entry 2

JOHNSON WESLEY · CIK 0001258791 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,095

SEC source: 0001140361-17-030643 · doc1.xml · nonDerivative · entry 1

JOHNSON WESLEY · CIK 0001258791 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,974

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-17-028594 · doc1.xml · nonDerivative · entry 1

REED JAN STERN · CIK 0001124181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 316

SEC source: 0001140361-17-029089 · doc1.xml · nonDerivative · entry 1

Richard Stark · CIK 0001539142 · SVP, GM - Oncology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,040

F1 · shares: The exempt disposition of 393 shares of common stock ("Common Stock") of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 22, 2015.

SEC source: 0001140361-17-029081 · doc1.xml · nonDerivative · entry 1

Trowbridge Stephen A · CIK 0001624250 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,679

F1 · shares: The exempt disposition of 397 shares of common stock ("Common Stock") of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 22, 2015.

SEC source: 0001140361-17-028409 · doc1.xml · nonDerivative · entry 2

Clemmer James C · CIK 0001476700 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,683

SEC source: 0001140361-17-028417 · doc1.xml · nonDerivative · entry 1

DONNELLY HOWARD W · CIK 0001212978 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,600

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.71 to $15.72, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.

SEC source: 0001140361-17-028409 · doc1.xml · nonDerivative · entry 1

Clemmer James C · CIK 0001476700 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,683

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.54 to $15.70, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.

SEC source: 0001140361-17-025746 · doc1.xml · derivative · entry 3

DONNELLY HOWARD W · CIK 0001212978 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,000 shares

Expires 2017-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Options for 33 1/3% of the total number of shares each became exercisable on 8/3/2011, 8/3/2012 and 8/3/2013.

SEC source: 0001140361-17-025746 · doc1.xml · nonDerivative · entry 2

DONNELLY HOWARD W · CIK 0001212978 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,600

SEC source: 0001140361-17-025746 · doc1.xml · nonDerivative · entry 1

DONNELLY HOWARD W · CIK 0001212978 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,144

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-17-022413 · doc1.xml · nonDerivative · entry 1

Campbell Chad Thomas · CIK 0001706852 · SVP/GM, Vascular Access

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,264

F1 · shares: The exempt disposition of 788 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016.

SEC source: 0001140361-17-016719 · doc1.xml · nonDerivative · entry 1

Trowbridge Stephen A · CIK 0001624250 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,076

F1 · shares: The exempt disposition of 1,585 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on April 24, 2015.

SEC source: 0000899243-17-010318 · doc4.xml · nonDerivative · entry 4

Burgstahler David F · CIK 0001374179 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 381,406

F3 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners (Offshore), L.P. ("ACP Offshore"). ACP GP is the general partner of ACP Offshore. By virtue of this relationship, ACP GP may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Offshore. Each of ACP GP and ACP Offshore expressly disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein.

SEC source: 0000899243-17-010318 · doc4.xml · nonDerivative · entry 3

Burgstahler David F · CIK 0001374179 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 505,189

F2 · ownership.nature: Represents shares of the Issuer held by Navilyst Medical Co-Invest, LLC ("NM Co-Invest"). ACP GP is the manager of NM Co-Invest. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Burgstahler may be deemed to share voting and dispositive power with respect to the shares of common stock held by NM Co-Invest. Mr. Burgstahler expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein.

SEC source: 0000899243-17-010318 · doc4.xml · nonDerivative · entry 2

Burgstahler David F · CIK 0001374179 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,446,413

F1 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners, L.P. ("ACP"). Avista Capital Partners GP, LLC ("ACP GP") is the general partner of ACP. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Burgstahler may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP. Mr. Burgstahler expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein.

SEC source: 0000899243-17-010317 · doc4.xml · nonDerivative · entry 3

Avista Capital Partners GP, LLC · CIK 0001374781 · 10% owner

Avista Capital Partners, L.P. · CIK 0001374541 · 10% owner

Avista Capital Partners (Offshore), L.P. · CIK 0001374540 · 10% owner

Navilyst Medical Co-Invest, LLC · CIK 0001550745 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 381,406

F3 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners (Offshore), L.P. ("ACP Offshore"). ACP GP is the general partner of ACP Offshore. By virtue of this relationship, ACP GP may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Offshore. Each of ACP GP and ACP Offshore expressly disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein.

SEC source: 0000899243-17-010317 · doc4.xml · nonDerivative · entry 2

Avista Capital Partners GP, LLC · CIK 0001374781 · 10% owner

Avista Capital Partners, L.P. · CIK 0001374541 · 10% owner

Avista Capital Partners (Offshore), L.P. · CIK 0001374540 · 10% owner

Navilyst Medical Co-Invest, LLC · CIK 0001550745 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 505,189

F2 · ownership.nature: Represents shares of the Issuer held by Navilyst Medical Co-Invest, LLC ("NM Co-Invest"). ACP GP is the manager of NM Co-Invest. By virtue of this relationship, ACP GP may be deemed to share voting and dispositive power with respect to the shares of common stock held by NM Co-Invest. Each of ACP GP and NM Co-Invest expressly disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein.

SEC source: 0000899243-17-010317 · doc4.xml · nonDerivative · entry 1

Avista Capital Partners GP, LLC · CIK 0001374781 · 10% owner

Avista Capital Partners, L.P. · CIK 0001374541 · 10% owner

Avista Capital Partners (Offshore), L.P. · CIK 0001374540 · 10% owner

Navilyst Medical Co-Invest, LLC · CIK 0001550745 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,446,413

F1 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners, L.P. ("ACP"). Avista Capital Partners GP, LLC ("ACP GP") is the general partner of ACP. By virtue of this relationship, ACP GP may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP. Each of ACP GP and ACP expressly disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein.

SEC source: 0001140361-17-015381 · doc1.xml · nonDerivative · entry 1

Clemmer James C · CIK 0001476700 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,683

F1 · shares: The exempt disposition of 4,508 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on April 4, 2016.

SEC source: 0001140361-17-002000 · doc1.xml · derivative · entry 3

LaPorte Steve · CIK 0001340404 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,000 shares

Expires 2017-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options became exercisable as to 4,667 shares on August 3, 2011, 4,667 shares on August 3, 2012 and 4,666 shares on August 3, 2013.

SEC source: 0001140361-17-002000 · doc1.xml · nonDerivative · entry 2

LaPorte Steve · CIK 0001340404 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,201

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.89 to $17.99, inclusive. The options exercised to purchase the shares were granted on 8/3/2010 and were set to expire on 8/3/2017. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1.

SEC source: 0001140361-17-002000 · doc1.xml · nonDerivative · entry 1

LaPorte Steve · CIK 0001340404 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,201

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-16-034113 · doc4.xml · nonDerivative · entry 4

Burgstahler David F · CIK 0001374179 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 765,590

F3 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners (Offshore), L.P. ("ACP Offshore"). ACP GP is the general partner of ACP Offshore. By virtue of this relationship, ACP GP may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Offshore. Each of ACP GP and ACP Offshore expressly disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein.

SEC source: 0000899243-16-034113 · doc4.xml · nonDerivative · entry 3

Burgstahler David F · CIK 0001374179 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,014,058

F2 · ownership.nature: Represents shares of the Issuer held by Navilyst Medical Co-Invest, LLC ("NM Co-Invest"). ACP GP is the manager of NM Co-Invest. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Burgstahler may be deemed to share voting and dispositive power with respect to the shares of common stock held by NM Co-Invest. Mr. Burgstahler expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein.

SEC source: 0000899243-16-034113 · doc4.xml · nonDerivative · entry 2

Burgstahler David F · CIK 0001374179 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,903,360

F1 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners, L.P. ("ACP"). Avista Capital Partners GP, LLC ("ACP GP") is the general partner of ACP. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Burgstahler may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP. Mr. Burgstahler expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein.

SEC source: 0000899243-16-034112 · doc4.xml · nonDerivative · entry 3

Avista Capital Partners GP, LLC · CIK 0001374781 · 10% owner

Avista Capital Partners, L.P. · CIK 0001374541 · 10% owner

Avista Capital Partners (Offshore), L.P. · CIK 0001374540 · 10% owner

Navilyst Medical Co-Invest, LLC · CIK 0001550745 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 765,590

F3 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners (Offshore), L.P. ("ACP Offshore"). ACP GP is the general partner of ACP Offshore. By virtue of this relationship, ACP GP may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Offshore. Each of ACP GP and ACP Offshore expressly disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein.

SEC source: 0000899243-16-034112 · doc4.xml · nonDerivative · entry 2

Avista Capital Partners GP, LLC · CIK 0001374781 · 10% owner

Avista Capital Partners, L.P. · CIK 0001374541 · 10% owner

Avista Capital Partners (Offshore), L.P. · CIK 0001374540 · 10% owner

Navilyst Medical Co-Invest, LLC · CIK 0001550745 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,014,058

F2 · ownership.nature: Represents shares of the Issuer held by Navilyst Medical Co-Invest, LLC ("NM Co-Invest"). ACP GP is the manager of NM Co-Invest. By virtue of this relationship, ACP GP may be deemed to share voting and dispositive power with respect to the shares of common stock held by NM Co-Invest. Each of ACP GP and NM Co-Invest expressly disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein.

SEC source: 0000899243-16-034112 · doc4.xml · nonDerivative · entry 1

Avista Capital Partners GP, LLC · CIK 0001374781 · 10% owner

Avista Capital Partners, L.P. · CIK 0001374541 · 10% owner

Avista Capital Partners (Offshore), L.P. · CIK 0001374540 · 10% owner

Navilyst Medical Co-Invest, LLC · CIK 0001550745 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,903,360

F1 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners, L.P. ("ACP"). Avista Capital Partners GP, LLC ("ACP GP") is the general partner of ACP. By virtue of this relationship, ACP GP may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP. Each of ACP GP and ACP expressly disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein.

SEC source: 0001140361-16-085625 · doc1.xml · derivative · entry 1

REED JAN STERN · CIK 0001124181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2023-11-07

F1 · derivative.exercise_date: These stock options vest in four equal annual installments beginning on November 7, 2017, such that 25% of the options will vest on each of November 7, 2017, 2018, 2019 and 2020.

SEC source: 0001140361-16-085623 · doc1.xml · derivative · entry 1

Auen Eileen O'Shea · CIK 0001428073 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2023-11-07

F1 · derivative.exercise_date: These stock options vest in four equal annual installments beginning on November 7, 2017, such that 25% of the options will vest on each of November 7, 2017, 2018, 2019 and 2020.

SEC source: 0001140361-16-079003 · doc1.xml · derivative · entry 3

GOLD JEFFREY · CIK 0000938659 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,000 shares

Expires 2016-09-04

F1 · derivative.exercise_date: Options for one-third of the shares each became exercisable on 09/04/2010, 09/04/2011 and 09/04/2012, respectively.

SEC source: 0001140361-16-079003 · doc1.xml · nonDerivative · entry 2

GOLD JEFFREY · CIK 0000938659 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,037

SEC source: 0001140361-16-079003 · doc1.xml · nonDerivative · entry 1

GOLD JEFFREY · CIK 0000938659 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-16-079006 · doc1.xml · derivative · entry 3

Meteny Dennis S · CIK 0001289336 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,000 shares

Expires 2016-09-04

F1 · derivative.exercise_date: Options for one-third of the shares each became exercisable on 09/04/2010, 09/04/2011 and 09/04/2012, respectively.

SEC source: 0001140361-16-079006 · doc1.xml · nonDerivative · entry 2

Meteny Dennis S · CIK 0001289336 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,151

SEC source: 0001140361-16-079006 · doc1.xml · nonDerivative · entry 1

Meteny Dennis S · CIK 0001289336 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,793

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.